Liabilities, Current of INFINITY PHARMACEUTICALS, INC. from 31 Dec 2010 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2010 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Liabilities, Current for the quarter ending 30 Jun 2023 was $12,064,000, a 16% decline year-over-year.
- Source SEC data
- View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Liabilities, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $12,064,000 | -$2,275,000 | -16% | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $11,289,000 | -$2,105,000 | -16% | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | $13,628,000 | +$328,000 | +2.5% | 31 Dec 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $14,200,000 | +$1,849,000 | +15% | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $14,339,000 | +$3,785,000 | +36% | 30 Jun 2022 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $13,394,000 | +$3,936,000 | +42% | 31 Mar 2022 | 10-Q | 03 May 2022 | 2022 | Q1 |
| Q4 2021 | $13,300,000 | +$2,253,000 | +20% | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2021 | $12,351,000 | +$2,517,000 | +26% | 30 Sep 2021 | 10-Q | 02 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $10,554,000 | +$1,677,000 | +19% | 30 Jun 2021 | 10-Q | 27 Jul 2021 | 2021 | Q2 |
| Q1 2021 | $9,458,000 | +$995,000 | +12% | 31 Mar 2021 | 10-Q | 13 May 2021 | 2021 | Q1 |
| Q4 2020 | $11,047,000 | +$1,349,000 | +14% | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
| Q3 2020 | $9,834,000 | +$1,085,000 | +12% | 30 Sep 2020 | 10-Q | 09 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $8,877,000 | +$687,000 | +8.4% | 30 Jun 2020 | 10-Q | 30 Jul 2020 | 2020 | Q2 |
| Q1 2020 | $8,463,000 | +$1,004,000 | +13% | 31 Mar 2020 | 10-Q | 11 May 2020 | 2020 | Q1 |
| Q4 2019 | $9,698,000 | +$1,980,000 | +26% | 31 Dec 2019 | 10-K | 16 Mar 2021 | 2020 | FY |
| Q3 2019 | $8,749,000 | +$2,644,000 | +43% | 30 Sep 2019 | 10-Q | 30 Oct 2019 | 2019 | Q3 |
| Q2 2019 | $8,190,000 | +$2,511,000 | +44% | 30 Jun 2019 | 10-Q | 30 Jul 2019 | 2019 | Q2 |
| Q1 2019 | $7,459,000 | +$2,917,000 | +64% | 31 Mar 2019 | 10-Q | 07 May 2019 | 2019 | Q1 |
| Q4 2018 | $7,718,000 | -$3,877,000 | -33% | 31 Dec 2018 | 10-K | 03 Mar 2020 | 2019 | FY |
| Q3 2018 | $6,105,000 | -$4,766,000 | -44% | 30 Sep 2018 | 10-Q | 05 Nov 2018 | 2018 | Q3 |
| Q2 2018 | $5,679,000 | -$5,257,000 | -48% | 30 Jun 2018 | 10-Q | 07 Aug 2018 | 2018 | Q2 |
| Q1 2018 | $4,542,000 | -$6,034,000 | -57% | 31 Mar 2018 | 10-Q | 08 May 2018 | 2018 | Q1 |
| Q4 2017 | $11,595,000 | -$12,268,000 | -51% | 31 Dec 2017 | 10-K | 14 Mar 2019 | 2018 | FY |
| Q3 2017 | $10,871,000 | -$15,029,000 | -58% | 30 Sep 2017 | 10-Q | 07 Nov 2017 | 2017 | Q3 |
| Q2 2017 | $10,936,000 | -$33,336,000 | -75% | 30 Jun 2017 | 10-Q | 03 Aug 2017 | 2017 | Q2 |
| Q1 2017 | $10,576,000 | -$56,196,000 | -84% | 31 Mar 2017 | 10-Q | 09 May 2017 | 2017 | Q1 |
| Q4 2016 | $23,863,000 | -$46,193,000 | -66% | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q3 2016 | $25,900,000 | -$48,412,000 | -65% | 30 Sep 2016 | 10-Q | 09 Nov 2016 | 2016 | Q3 |
| Q2 2016 | $44,272,000 | -$13,959,000 | -24% | 30 Jun 2016 | 10-Q | 09 Aug 2016 | 2016 | Q2 |
| Q1 2016 | $66,772,000 | +$22,451,000 | +51% | 31 Mar 2016 | 10-Q | 04 May 2016 | 2016 | Q1 |
| Q4 2015 | $70,056,000 | +$15,179,000 | +28% | 31 Dec 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q3 2015 | $74,312,000 | +$15,899,000 | +27% | 30 Sep 2015 | 10-Q | 05 Nov 2015 | 2015 | Q3 |
| Q2 2015 | $58,231,000 | +$31,725,000 | +120% | 30 Jun 2015 | 10-Q | 06 Aug 2015 | 2015 | Q2 |
| Q1 2015 | $44,321,000 | +$18,198,000 | +70% | 31 Mar 2015 | 10-Q | 06 May 2015 | 2015 | Q1 |
| Q4 2014 | $54,877,000 | +$32,671,000 | +147% | 31 Dec 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q3 2014 | $58,413,000 | +$34,877,000 | +148% | 30 Sep 2014 | 10-Q | 10 Nov 2014 | 2014 | Q3 |
| Q2 2014 | $26,506,000 | +$5,660,000 | +27% | 30 Jun 2014 | 10-Q | 11 Aug 2014 | 2014 | Q2 |
| Q1 2014 | $26,123,000 | +$8,836,000 | +51% | 31 Mar 2014 | 10-Q | 06 May 2014 | 2014 | Q1 |
| Q4 2013 | $22,206,000 | +$3,543,000 | +19% | 31 Dec 2013 | 10-K | 24 Feb 2015 | 2014 | FY |
| Q3 2013 | $23,536,000 | +$5,678,000 | +32% | 30 Sep 2013 | 10-Q | 07 Nov 2013 | 2013 | Q3 |
| Q2 2013 | $20,846,000 | -$16,241,000 | -44% | 30 Jun 2013 | 10-Q | 08 Aug 2013 | 2013 | Q2 |
| Q1 2013 | $17,287,000 | -$10,948,000 | -39% | 31 Mar 2013 | 10-Q | 07 May 2013 | 2013 | Q1 |
| Q4 2012 | $18,663,000 | -$10,323,000 | -36% | 31 Dec 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q3 2012 | $17,858,000 | -$7,577,590 | -30% | 30 Sep 2012 | 10-Q | 06 Nov 2012 | 2012 | Q3 |
| Q2 2012 | $37,087,000 | +$15,933,958 | +75% | 30 Jun 2012 | 10-Q | 07 Aug 2012 | 2012 | Q2 |
| Q1 2012 | $28,235,000 | 31 Mar 2012 | 10-Q | 08 May 2012 | 2012 | Q1 | ||
| Q4 2011 | $28,986,000 | +$1,235,395 | +4.5% | 31 Dec 2011 | 10-K | 05 Mar 2013 | 2012 | FY |
| Q3 2011 | $25,435,590 | 30 Sep 2011 | 10-Q | 08 Nov 2011 | 2011 | Q3 | ||
| Q2 2011 | $21,153,042 | 30 Jun 2011 | 10-Q | 09 Aug 2011 | 2011 | Q2 | ||
| Q4 2010 | $27,750,605 | 31 Dec 2010 | 10-K | 13 Mar 2012 | 2011 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.